Ventus Therapeutics
Biotechnology company focused on discovering and developing small-molecule medicines that target innate immune system pathways, addressing inflammation and immune-mediated diseases.
Website
https://www.ventustx.comLocation
Waltham, Massachusetts, USA
Founded
2018
Investors
1
Categories
therapeutics, biotech, immunology, small-molecule, innate-immunity
Notes
Ventus Therapeutics is a biotechnology company focused on discovering and developing small-molecule medicines that target innate immune system pathways. The company is headquartered in Waltham, Massachusetts.
The innate immune system is the body's first line of defense against pathogens and plays a key role in inflammation. Dysregulation of innate immune pathways contributes to many diseases, including:
- Autoimmune conditions
- Inflammatory diseases
- Certain cancers
- Neurodegenerative diseases
Ventus is developing small molecules that modulate key innate immune sensors and pathways to treat these conditions.
Team
- Marcelo Bhardwaj - Chief Executive Officer
- LinkedIn: linkedin.com/in/marcelobhardwaj
Additional Research Findings
- Investor: Alexandria Venture Investments
- Focus on small-molecule medicines
- Innate immune system targeting
- Inflammation and immune-mediated disease focus
- Waltham, Massachusetts headquarters
- Founded in 2018
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Alexandria Venture Investments | Pasadena, USA | cvc | seedseries-a+3 | 6 |